S-adenosyl-L-methionine protects the liver against the cholestatic, cytotoxic, and vasoactive effects of leukotriene D4: A study with isolated and perfused rat liver

Hepatology

Volumn 26, Issue 2, 1997, Pages 330-335

  Cincu, Rafael N ^a   Rodríguez Ortigosa, Carlos M ^a   Vesperinas, Idoia ^a   Quiroga, Jorge ^a   Prieto, Jesús ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILE SALT; LACTATE DEHYDROGENASE; LEUKOTRIENE D4; S ADENOSYLMETHIONINE;

ANIMAL TISSUE; ARTICLE; BILE FLOW; CHOLESTASIS; CYTOTOXICITY; DOSE RESPONSE; ISOLATED LIVER; LIVER INJURY; LIVER PERFUSION; MALE; NONHUMAN; PERFUSION PRESSURE; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT;

ANIMALS; BILE; BILE ACIDS AND SALTS; CHOLESTASIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODYNAMIC PROCESSES; LEUKOTRIENE D4; LIVER; MALE; PERFUSION; RATS; RATS, WISTAR; S-ADENOSYLMETHIONINE;

EID: 0030808101     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260212     Document Type: Article

References (30)

1. Keppler D. Leukotrienes and other eicosanoids in liver pathophysiology. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter D, Shafritz DA, eds. The Liver: Biology and Pathobiology. 3rd Ed. New York: Raven, 1994:1015-1029.
2. Hagmann W, Steffan AM, Kirn A, Keppler D. Leukotrienes as mediators in frog virus 3-induced hepatitis in rats. HEPATOLOGY 1987;7:732-736.
3. Tiegs G, Wendel A. Leukotriene-mediated liver injury. Biochem Pharmacol 1988;37:2569-2573.
4. 4-stimulated choleresis in isolated rat liver. Gastroenterology 1995;108:1793-1801.
5. 2 analogue U-46619 in isolated perfused rat liver. Metabolic, hemodynamic and ion-flux responses. Biol Chem Hoppe-Seyler 1988;369:97-107.
6. 4 in isolated perfused rat liver. HEPATOLOGY 1989;10:300-305.
7. Keppler D, Hagmann W, Rapp S, Denzlinger C, Koch HK. The relation of leukotrienes to liver injury. HEPATOLOGY 1985;5:883-891.
8. Samuelsson B. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 1983;220:568-575.
9. Cantoni GL. S-Adenosylmethionine: A new intermediate formed enzymatically from L-methionine and adenosine-triphosphate. J Biol Chem 1953;204:403-416.
10. Palmerini CA, Corazzi L, Arienti G. The action of S-adenosyl-L-methionine on the levels of triglyceride and phospholipid precursors in ethanol-intoxicated rat liver. Farmaco Sci 1981;36:942-946.
11. Stramentinoli G, Pezzoli C, Galli-Kienle M. Protective role of S-adenosyl-L-methionine against acetaminophen induced mortality and hepatotoxicity in mice. Biochem Pharmacol 1979;28:3567-3571.
12. Stramentinoli G, Gualano M, Ideo G. Protective role of S-adenosyl-L-methionine on liver injury induced by D-galactosamine in rats. Biochem Pharmacol 1978;27:1431-1433.
13. Corrales F, Giménez A, Alvarez L, Caballería J, Pajares MA, Andreu H, Parés A, et al. S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury. HEPATOLOGY 1992;16:1022-1027.
14. +-ATPase, membrane fluidity, and bile flow in rats with ethinyl estradiol-induced cholestasis. HEPATOLOGY 1983;3:12-17.
15. Miller RG. Simultaneous Statistical Inference. 2nd edition. New York: Springer-Verlag, 1981.
16. Keppler D, Huber M, Baumert T. Leukotrienes as mediators in diseases of the liver. Semin Liver Dis 1988;8:357-366.
17. Wettstein M, Gerok W, Häussinger D. Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Hepatocyte heterogeneity in uptake and biliary excretion. Eur J Biochem 1989;181:115-124.
18. Ishikawa T, Müller M, Klünemann C, Schaub T, Keppler D. ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. J Biol Chem 1990;265:19279-19286.
19. Keppler D, Müller M, Böhme M, Mansur-Garza E. ATP-dependent transport across the hepatocyte canalicular membrane. In: Messmer K, Menger MD, eds. Liver Microcirculation and Hepatobiliary Function. Basel, Switzerland: Karger S, 1993:15-23.
20. Piper PJ. Formation and actions of leukotrienes. Physiol Rev 1984;64:744-761.
21. Stramentinoli G, Di Padova C, Gualano M, Rovagnati P, Galli-Kienle M. Ethynylestradiol-induced impairment of bile secretion in the rat: Protective effects of S-adenosyl-L-methionine and its implication in estrogen metabolism. Gastroenterology 1981;80:154-158.
22. Belli DC, Fournier L, Lepage G, Yousef I, Roy CC. S-adenosylmethionine prevents total parenteral nutrition-induced cholestasis in the rat. J Hepatol 1994;21:18-23.
23. Bilzer M, Lauterburg BH. Peptidoleukotrienes increase the efflux of glutathione from perfused rat liver. Prostagland Leuk Essent Fatty Acids 1993;49:715-721.
24. Lieber CS, Casini A, DeCarli LM, Kim C, Lowe N, Sasaki R, Leo MA. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. HEPATOLOGY 1990;11:165-172.
25. DeLeve LD, Kaplowitz N. Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther 1991;52:287-305.
26. Corrales F, Cabrero C, Pajares MA, Ortiz P, Martín-Duce A, Mato JM. Inactivation and dissociation of S-adenosylmethionine synthetase by modification of sulfhydryl groups and its possible occurrence in cirrhosis. HEPATOLOGY 1990;11:216-222.
27. Samuelsson B, Dahlén S, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 1987;237:1171-1176.
28. Keppler D, Guhlmann A, Huber M. Metabolism and action of leukotrienes in vivo. In: Messmer K, Hammersen F, eds. Gastrointestinal microcirculation. Basel, Switzerland: Karger S, 1990:129-141.
29. Snyder DW, Fleisch JH. Leukotriene receptor antagonists as potential therapeutic agents. Annu Rev Pharmacol Toxicol 1989;29:123-143.
30. Uehara N, Ormstad K, Orning L, Hammarström S. Characteristics of the uptake of cysteine-containing leukotrienes by isolated hepatocytes. Biochim Biophys Acta 1983;732:69-74.